Pfizer
Essays

Pfizer is one of the world's largest pharmaceutical corporations and a frequent subject of academic study across business, ethics, public health, and marketing courses. Students examine the company because it sits at the intersection of several complex forces: competitive drug markets, intellectual property law, corporate governance, and global health policy. Its products, pricing strategies, and business conduct generate ongoing debate, making it a rich subject for courses in business ethics, strategic management, and healthcare economics.

The papers archived on this topic reflect a wide range of analytical approaches. SWOT analyses and financial analyses assess Pfizer's market position, competitive landscape, and business performance. Other papers take an ethical or policy-oriented angle, exploring issues such as unethical experimentation and the relationship between pharmaceutical companies, intellectual property rights, and the global AIDS epidemic. Case-study approaches examine specific products like Viagra, while comparative papers place Pfizer alongside other industry competitors to evaluate marketing strategies and corporate decision-making. Biographical work, such as writing on Dr. Jeffrey Wigand's contributions to business ethics, situates the company within broader conversations about corporate accountability.

A strong essay on Pfizer benefits from a clearly scoped thesis rather than a general overview of the company. Whether the focus is financial performance, marketing strategy, or ethical conduct, the argument should be grounded in specific evidence — industry data, documented corporate decisions, or policy outcomes — rather than broad claims about the pharmaceutical sector. A common pitfall is treating Pfizer in isolation; situating its practices within wider industry competition and regulatory environments produces far more persuasive analysis.